http://bio2rdf.org/drugbank_resource:DB00214_DB00359_nanopub.RADI80y1p0Ev_lmlt87GvUEivmG8yXVjFYrHiix4cpAJs#head http://bio2rdf.org/drugbank_resource:DB00214_DB00359_nanopub.RADI80y1p0Ev_lmlt87GvUEivmG8yXVjFYrHiix4cpAJs http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00214_DB00359_nanopub.RADI80y1p0Ev_lmlt87GvUEivmG8yXVjFYrHiix4cpAJs#assertion http://bio2rdf.org/drugbank_resource:DB00214_DB00359_nanopub.RADI80y1p0Ev_lmlt87GvUEivmG8yXVjFYrHiix4cpAJs http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00214_DB00359_nanopub.RADI80y1p0Ev_lmlt87GvUEivmG8yXVjFYrHiix4cpAJs#provenance http://bio2rdf.org/drugbank_resource:DB00214_DB00359_nanopub.RADI80y1p0Ev_lmlt87GvUEivmG8yXVjFYrHiix4cpAJs http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00214_DB00359_nanopub.RADI80y1p0Ev_lmlt87GvUEivmG8yXVjFYrHiix4cpAJs#publicationInfo http://bio2rdf.org/drugbank_resource:DB00214_DB00359_nanopub.RADI80y1p0Ev_lmlt87GvUEivmG8yXVjFYrHiix4cpAJs http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00214_DB00359_nanopub.RADI80y1p0Ev_lmlt87GvUEivmG8yXVjFYrHiix4cpAJs#assertion http://bio2rdf.org/drugbank:DB00214 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00214_DB00359 http://bio2rdf.org/drugbank:DB00359 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00214_DB00359 http://bio2rdf.org/drugbank_resource:DB00214_DB00359 http://purl.org/dc/terms/identifier drugbank_resource:DB00214_DB00359 http://bio2rdf.org/drugbank_resource:DB00214_DB00359 http://purl.org/dc/terms/title DDI between Torasemide and Sulfadiazine - Sulfadiazine, a strong CYP2C9 inhibitor, may increase the serum concentration of Torasemide, a CYP2C9 substrate, by decreasing Torasemide metabolism and clearance. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of Torasemide if Sulfadiazine is initiated, discontinued or dose changed. http://bio2rdf.org/drugbank_resource:DB00214_DB00359 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00214_DB00359 http://www.w3.org/2000/01/rdf-schema#label DDI between Torasemide and Sulfadiazine - Sulfadiazine, a strong CYP2C9 inhibitor, may increase the serum concentration of Torasemide, a CYP2C9 substrate, by decreasing Torasemide metabolism and clearance. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of Torasemide if Sulfadiazine is initiated, discontinued or dose changed. [drugbank_resource:DB00214_DB00359] http://bio2rdf.org/drugbank_resource:DB00214_DB00359_nanopub.RADI80y1p0Ev_lmlt87GvUEivmG8yXVjFYrHiix4cpAJs#provenance http://bio2rdf.org/drugbank_resource:DB00214_DB00359_nanopub.RADI80y1p0Ev_lmlt87GvUEivmG8yXVjFYrHiix4cpAJs#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00214_DB00359_nanopub.RADI80y1p0Ev_lmlt87GvUEivmG8yXVjFYrHiix4cpAJs#publicationInfo http://bio2rdf.org/drugbank_resource:DB00214_DB00359_nanopub.RADI80y1p0Ev_lmlt87GvUEivmG8yXVjFYrHiix4cpAJs#signature.MC0CFGRYdAmI37UZ http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00214_DB00359_nanopub.RADI80y1p0Ev_lmlt87GvUEivmG8yXVjFYrHiix4cpAJs#signature.MC0CFGRYdAmI37UZ http://purl.org/nanopub/x/hasSignature MC0CFGRYdAmI37UZ8FFcdZGDtMGgWK+0AhUAgOEuPEbVRi3S77JnlycIupk8OAs= http://bio2rdf.org/drugbank_resource:DB00214_DB00359_nanopub.RADI80y1p0Ev_lmlt87GvUEivmG8yXVjFYrHiix4cpAJs#signature.MC0CFGRYdAmI37UZ http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00214_DB00359_nanopub.RADI80y1p0Ev_lmlt87GvUEivmG8yXVjFYrHiix4cpAJs http://purl.org/dc/terms/created 2018-03-30T11:12:53.551+02:00 http://bio2rdf.org/drugbank_resource:DB00214_DB00359_nanopub.RADI80y1p0Ev_lmlt87GvUEivmG8yXVjFYrHiix4cpAJs http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00214_DB00359_nanopub.RADI80y1p0Ev_lmlt87GvUEivmG8yXVjFYrHiix4cpAJs http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00214_DB00359_nanopub.RADI80y1p0Ev_lmlt87GvUEivmG8yXVjFYrHiix4cpAJs#signature.MC0CFGRYdAmI37UZ http://bio2rdf.org/drugbank_resource:DB00214_DB00359_nanopub.RADI80y1p0Ev_lmlt87GvUEivmG8yXVjFYrHiix4cpAJs http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234